Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer.

ABSTRACT:

SUBMITTER: Maltoni R 

PROVIDER: S-EPMC9073799 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature